Skip to content
Events

Details

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
Nov 7, 2019
3:00 PM
Location
North America
Affiliation
Illumina, Inc.
Presenter
Phil Febbo
Topic
Oncology, Cancer research
Watch Now

Related Events

Apr 19
From circulating signals to spatial context: Multiomic insights for next‑generation cancer research
Apr 19, 2026
Connect circulating DNA and methylation signals with spatial transcriptomics to sharpen cancer detection and insight.
View Event
Apr 19
Connect with Illumina at a major cancer research conference
Apr 19, 2026 – Apr 22, 2026
Multiomic liquid biopsy to spatial insights. Attend our Exhibitor Spotlight Theater April 19 and visit Illumina booth 4727.
View Event
May 14
Comprehensive Genomic Profiling (CGP) advancing Precision Oncology
May 14, 2026
Comprehensive Genomic Profiling (CGP) is redefining standard of care in precision oncology enabling nucleotide-level resolution of a tumor’s complete genomic landscape in a single comprehensive assay. Unlike iterative multiple single-gene tests, FISH-PCR-single gene or small hotspot panels, CGP uses advanced technologies such as next-generation sequencing to detect a broad range of genetic alterations, including mutations, copy number changes, structural variants and large genomic signatures (TMB, MSI, HRD).
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.